InsidersTradesSigma
Track the 경보제약 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 경보제약 has recorded 28 public disclosures. Market capitalisation: €124.3bn. The latest transaction was disclosed on 19 March 2026 (Purchase). Among the most active insiders: 종근당홀딩스. Every trade is free.
28
Insider Decl.
n/a
Thresholds
€6,454
22 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,994 of 28,833 companies
28.2
score / 100
Value26
Quality30
FCF yld-27%
Earn yld0.1%
EV/EBITDA14.0x
ROE0.2%
Gross mgn39%
Net mgn0.1%
Debt/EBITDA7.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 March 2026
Declarations28 total
25 of 28 declarations
About 경보제약
경보제약 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the research and development of innovative medications.